PEMETREXED Accord liquid 100 mg/4ml flac
7680678110015
CH-67811
L01BA04
07.16.1.
Reimbursement limitations:
PEMETRACC.02
PEMETREXED ACCORD LIQUID est remboursé comme thérapie de première ligne en association avec osimertinib et …
1 / 3
google
Details
- Product number
- 6781101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- pemetrexedum 100 mg ut pemetrexedum dinatricum hemipentahydricum, acidum citricum, methioninum, thioglycerolum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile, pro vitro corresp. natrium 33.76 mg.
Articles (1)
Pemetrexed Accord liquid 100 mg, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
33.76 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 108.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2021
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 67811
- Drug name
- Pemetrexed Accord liquid, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01BA04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 02/03/2021
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PEMETREXED Accord liquid 100 mg/4ml flac
- Description (DE)
- PEMETREXED Accord liquid 100 mg/4ml Durchstf
- Market launch
- 02/03/2021
- Narcotic (BTM)
- No